tiprankstipranks
Trending News
More News >
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
US Market

Compare Arvinas Holding Company (ARVN) vs. Competitors

Compare
1,040 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Arvinas Holding Company
$12.20
$783.54M
-15.19
-29.15%
6 Buy
3 Hold
1 Sell
Moderate Buy
AnaptysBio
$50.26
$1.39B
-17.83
237.09%
9 Buy
1 Hold
0 Sell
Strong Buy
Meiragtx Holdings
$7.45
$599.66M
29.12%
6 Buy
0 Hold
0 Sell
Strong Buy
Compass Therapeutics
$6.04
$1.07B
-13.20
202.00%
8 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$28.77
$2.26B
-15.88
459.73%
11 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$18.02
$987.17M
-8.08
40.40%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARVN
Arvinas Holding Company
12.20
-5.38
-30.60%
ANAB
AnaptysBio
50.26
35.23
234.40%
MGTX
Meiragtx Holdings
7.45
1.52
25.63%
CMPX
Compass Therapeutics
6.04
3.54
141.60%
OLMA
Olema Pharmaceuticals
28.77
23.49
444.89%
BCAX
Bicara Therapeutics Inc.
18.02
6.14
51.68%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts